Mortality reduction with PCSK9 inhibition: A case of cautious optimism

Authors

Dave L. Dixon, Virginia Commonwealth University, USA.
Salim S. Virani, Michael E. DeBakey VA Medical Center, USA.Follow

Document Type

Editorial

Department

Office of the Provost; Cardiology

Comments

This work was published before the author joined Aga Khan University.

Publication (Name of Journal)

Journal of Clinical Lipidology

DOI

10.1016/j.jacl.2019.06.012

Recommended Citation

Dixon, D. L., Virani, S. S. (2019). Mortality reduction with PCSK9 inhibition: A case of cautious optimism. Journal of Clinical Lipidology, 13(5), 712-713.
Available at: https://ecommons.aku.edu/provost_office/634